Sildenafil citrate (Viagra drug, Pfizer) is still the front-line treatment for men with erectile dysfunction (ED), but for men who do not respond to it, intraurethral alprostadil (Caverject®, Pfizer) might be a good next choice. Researchers observed 44 men for up to 15 months. In 10 patients, ED was a result of radical retropubic prostatectomy. [...]
The FDA has approved updated labeling for three oral medications used to treat erectile dysfunction to reflect a small number of postmarketing reports of sudden vision loss attributed to non-arteritic ischemic optic neuropathy (naion). In patients with naion, blood flow to the optic nerve is blocked. The FDA advises patients to stop taking tadalafil drug [...]
Pfizer has agreed to change the label for Viagra® (sildenafil tablet), its medication for erectile dysfunction, to warn doctors about sudden vision loss in some men who took the drug. The FDA is asking all makers of impotence drugs to include similar warnings. No “causal relationship” has been made between Viagra® and the condition, a [...]
The FDA said that it was looking into cases of impaired vision among men with erectile dysfunction who took sildenafil (Viagra generic, Pfizer). Other cases have been reported in men taking tadalafil (Cialis drug, Eli Lilly ICOS) and vardenafil (Levitra medication, GlaxoSmithKline/Schering-Plough/Bayer AG). The warning labels for these drugs already mention the possibility of temporary [...]
The FDA has granted approval for Teva Pharmaceuticals to market the generic version of Merck’s Proscar drug (finasteride 5 mg) tablets. Finasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland and to reduce the need for prostate surgery.
